East Bay company eyes first drug approval after decade-long journey


The company has burned through $400 million, laid off employees and lost two Big Pharma partnerships, but now it is near an FDA drug approval for people with a debilitating bowel disorder.

Previous AG Healey refusing to join Purdue Pharma settlement
Next OHA confirms second vaping illness, cautions against using e-cigarettes